Oxygen-enabled composition
US-9980909-B2 · May 29, 2018 · US
Oxygen-enabled composition
US10137146B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10137146-B2 |
| Application number | US-201815983602-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 18, 2018 |
| Priority date | Mar 30, 2016 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A composition of chlorine-free poly-oxygenated metal hydroxide that comprises a clathrate containing oxygen gas molecules, and which may comprise a nutraceutical. In one embodiment, the poly-oxygenated metal hydroxide composition is soluble, and may have particles having a diameter of 212 μm or less. The poly-oxygenated metal hydroxide may comprise of a poly-oxygenated aluminum hydroxide. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form, where the poly-oxygenated aluminum hydroxide is soluble in the fluid.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition, comprising: a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free and soluble in a fluid. 2. The composition as specified in claim 1 , further comprising a nutraceutical selected from the group consisting of a protein, a vitamin, fiber, and electrolytes. 3. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide comprises particles each having a diameter of less than or equal to 212 μm. 4. The composition as specified in claim 3 , wherein the poly-oxygenated aluminum hydroxide is homogeneous. 5. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide is configured to be orally delivered and absorbed through lining of a stomach and a small intestine of a mammal. 6. The composition as specified in claim 1 , wherein poly-oxygenated aluminum metal hydroxide is configured to be therapeutically effective in treating a condition of a mammal. 7. The composition as specified in claim 1 , further comprising a fluid having a concentration of at least 1 milligram of the poly-oxygenated aluminum hydroxide to 8 fluid ounces of the fluid. 8. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide is configured to not create an immune response of the mammal. 9. The corn position as specified in claim 1 , wherein the particles each have a diameter in the range of 107-212 μm. 10. The corn position as specified in claim 1 , wherein the particles each have a diameter in the range of 46-106 μm. 11. The composition as specified in claim 1 , wherein the particles each have a diameter in the range of 26-45 μm. 12. A composition, comprising: a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free, a nutraceutical; and wherein the composition comprises particles each having a diameter of less than or equal to 212 μm. 13. The composition as specified in claim 12 further comprising a fluid, wherein the fluid comprises at least 1 milligram of the poly-oxygenated aluminum hydroxide to 8 fluid ounces of the fluid. 14. The corn position as specified in claim 12 , wherein the nutraceutical is selected from the group consisting of a protein, a vitamin, fiber, mineral and electrolytes. 15. The composition as specified in claim 14 , wherein the nutraceutical comprises a protein. 16. The composition as specified in claim 14 , wherein t e nutraceutical comprises an electrolyte. 17. The composition as specified in claim 12 , wherein poly-oxygenated aluminum hydroxide is configured to be therapeutically effective in treating a condition of a mammal.
Assignees
Inventors
Classifications
Submicrometer sized, i.e. from 0.1-1 micrometer · CPC title
Inorganic compounds · CPC title
inclusion complexes, e.g. clathrates, cavitates or fullerenes · CPC title
Grinding, deagglomeration or disintegration · CPC title
Processes · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10137146B2 cover?
- A composition of chlorine-free poly-oxygenated metal hydroxide that comprises a clathrate containing oxygen gas molecules, and which may comprise a nutraceutical. In one embodiment, the poly-oxygenated metal hydroxide composition is soluble, and may have particles having a diameter of 212 μm or less. The poly-oxygenated metal hydroxide may comprise of a poly-oxygenated aluminum hydroxide. The n…
- Who is the assignee on this patent?
- Woodmansee Jr John W, Woodmansee Robert A, Bruce Erica D, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K33/08. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).